Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Converge Coverage

  • 1
    News

    New heart failure trial data presage guideline revisions

    December 9, 2019

    PHILADELPHIA – Recent trial findings for sacubitril/valsartan and dapagliflozin in heart failure patients provide a blueprint for guideline changes.

  • 1
    News

    Aspirin plus a DOAC may do more harm than good in some

    December 8, 2019

    Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.

  • 1
    News

    Gunshot wound victims are at high risk for readmission

    December 4, 2019

    CHICAGO – Long-term outcomes of gun violence are still largely unknown.

  • 1
    News

    ACGME deepening its commitment to physician well-being, leader says

    November 27, 2019

    NEW ORLEANS – Positive social relationships with others are crucial to joy and well-being in the practice of medicine, Dr. Brigham said.

  • 1
    News

    DAPA-HF: Dapagliflozin benefits regardless of age, HF severity

    November 25, 2019

    PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.

  • 1
    News

    Large population-based study underscores link between gout, CVD event risk

    November 23, 2019

    ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.

  • News

    What’s new in hepatitis C: Four themes that dominated at the Liver Meeting

    November 22, 2019

    BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy, benefits of sustained virologic response, preemptive therapy in donor-positive organ transplant.

  • 1
    News

    Geriatric IBD hospitalization carries steep inpatient mortality

    November 21, 2019

    SAN ANTONIO – A major unmet need exists for better guideline-directed management of geriatric patients hospitalized for IBD.

  • 1
    News

    Findings confirm link between methimazole and risk for acute pancreatitis

    November 21, 2019

    CHICAGO – However, there is no evidence of a cumulative dose effect.

  • 1
    News

    Pulmonary embolism treatment teams adopted widely for complex disease

    November 20, 2019

    NEW YORK – The challenge of pulmonary embolism is being increasingly addressed with dedicated teams.

Previous1 … 42 43 44 45 46 … 105Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences